The 2010 ACR/EULAR criteria are not sufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: Results from the Leiden-EAC and ESPOIR cohorts
- PMID: 28601249
- DOI: 10.1016/j.semarthrit.2017.04.009
The 2010 ACR/EULAR criteria are not sufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: Results from the Leiden-EAC and ESPOIR cohorts
Abstract
Objectives: The 2010 ACR/EULAR criteria were derived to classify rheumatoid arthritis (RA) earlier in time. Previous studies indeed observed that the 2010 criteria were fulfilled earlier than the 1987 criteria. This study determined whether the 2010 criteria perform equally in early classification of autoantibody-positive and autoantibody-negative RA.
Methods: From the total Leiden-EAC (n = 3448) and ESPOIR (n = 813) RA patients who fulfilled the 1987 RA criteria at 1 year but not at presentation were selected (n = 463 and n = 53, respectively), as these patients were classified with delay with the 1987 criteria. These RA patients were studied on fulfilling the 2010 criteria at baseline (as 2010 positivity indicated that these RA patients were earlier identified) and these analyses were stratified for patients with and without anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF). Analyses were repeated for DMARD start within the first year as reference for RA (instead of fulfilling the 1987 criteria).
Results: In the EAC, 75% of the selected RA patients did already fulfill the 2010 criteria at baseline. In ESPOIR this was 57%, indeed demonstrating early classification with the 2010 criteria. Among the selected autoantibody-positive RA patients of the EAC, 93% was already identified at baseline with the 2010 criteria. Within autoantibody-negative RA this was 51% (p < 0.001), indicating that 49% of autoantibody-negative RA patients were not early classified with the 2010 criteria. Similarly, within autoantibody-positive RA patients in ESPOIR 92% were 2010 positive at baseline, whereas this was only 25% within autoantibody-negative RA (p < 0.001), indicating that 75% of autoantibody-negative RA patients were not early classified with the 2010 criteria. Similar results were obtained when DMARD start was the reference for RA.
Conclusions: The 2010 criteria perform well in the early identification of autoantibody-positive RA, but autoantibody-negative RA patients are still frequently missed with these criteria. This implies that other diagnostics are required for ACPA-negative patients.
Keywords: Autoantibodies; Classification criteria; Rheumatoid arthritis.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.Arthritis Res Ther. 2018 May 3;20(1):94. doi: 10.1186/s13075-018-1591-2. Arthritis Res Ther. 2018. PMID: 29724250 Free PMC article.
-
The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical.Arthritis Res Ther. 2017 May 31;19(1):115. doi: 10.1186/s13075-017-1324-y. Arthritis Res Ther. 2017. PMID: 28569212 Free PMC article.
-
Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort.Arthritis Res Ther. 2019 Jun 6;21(1):140. doi: 10.1186/s13075-019-1909-8. Arthritis Res Ther. 2019. PMID: 31171038 Free PMC article.
-
Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.Arthritis Rheumatol. 2018 Nov;70(11):1721-1731. doi: 10.1002/art.40562. Epub 2018 Sep 16. Arthritis Rheumatol. 2018. PMID: 29781231 Review.
-
Are seronegative patients with rheumatoid arthritis and clinically suspect arthralgia properly represented in randomized clinical trials?Clin Rheumatol. 2025 Jan;44(1):515-519. doi: 10.1007/s10067-024-07187-w. Epub 2024 Oct 26. Clin Rheumatol. 2025. PMID: 39455473 Free PMC article. Review.
Cited by
-
Current Status of Functional Studies on Circular RNAs in Rheumatoid Arthritis and Their Potential Role as Diagnostic Biomarkers.J Inflamm Res. 2021 Mar 30;14:1185-1193. doi: 10.2147/JIR.S302846. eCollection 2021. J Inflamm Res. 2021. PMID: 33833541 Free PMC article. Review.
-
Current situation and trend of non-coding RNA in rheumatoid arthritis: a review and bibliometric analysis.Front Immunol. 2024 Jan 16;14:1301545. doi: 10.3389/fimmu.2023.1301545. eCollection 2023. Front Immunol. 2024. PMID: 38292492 Free PMC article.
-
Disentangling heterogeneity in contemporary undifferentiated arthritis - A large cohort study using latent class analysis.Semin Arthritis Rheum. 2023 Dec;63:152251. doi: 10.1016/j.semarthrit.2023.152251. Epub 2023 Aug 9. Semin Arthritis Rheum. 2023. PMID: 37607441 Free PMC article.
-
Differing X-ray patterns in seronegative and seropositive rheumatoid arthritis.Clin Rheumatol. 2019 Sep;38(9):2403-2410. doi: 10.1007/s10067-019-04602-5. Epub 2019 May 23. Clin Rheumatol. 2019. PMID: 31123977
-
Late-onset rheumatoid arthritis: clinical features, diagnostic challenges, and treatment approaches.Rheumatol Int. 2025 Jun 9;45(6):152. doi: 10.1007/s00296-025-05908-1. Rheumatol Int. 2025. PMID: 40488895 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical